| scholarly article | Q13442814 |
| P50 | author | Xiao-Yan Jiang | Q83183601 |
| Jian-Jun Chen | Q89628907 | ||
| P2093 | author name string | Ning Li | |
| Jing Xie | |||
| Wuquan Deng | |||
| Liyin Chai | |||
| P2860 | cites work | Measuring inconsistency in meta-analyses | Q27860655 |
| Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. | Q33864120 | ||
| Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus | Q34385405 | ||
| Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial | Q34766176 | ||
| Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers | Q36467602 | ||
| Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal | Q37023534 | ||
| Psychosocial interventions for people with diabetes and co-morbid depression. A systematic review | Q38539289 | ||
| Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed Type 2 Diabetes Mellitus | Q43199078 | ||
| Interpretation of random effects meta-analyses. | Q43810883 | ||
| Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors | Q44442589 | ||
| Evaluation of the repaglinide efficiency in comparison to the glimepiride in the type 2 diabetes patients poorly regulated by the metmorfine administration. | Q45918977 | ||
| Psychosocial intervention for patients with type 2 diabetes mellitus and comorbid depression: a meta-analysis of randomized controlled trials | Q47138743 | ||
| Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. | Q51578788 | ||
| Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. | Q51734662 | ||
| Meta-analyses of randomized controlled trials. | Q52603476 | ||
| Urinary biomarker panel for diagnosing patients with depression and anxiety disorders | Q57155162 | ||
| GC-MS-based metabolomics approach to diagnose depression in hepatitis B virus-infected patients with middle or old age | Q57161916 | ||
| Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Q57412648 | ||
| Type 2 diabetes mellitus | Q58447602 | ||
| Antioxidant modifications induced by the new metformin derivative HL156A regulate metabolic reprogramming in SAMP1/kl (-/-) mice | Q58735442 | ||
| Urinary metabolite signature in bipolar disorder patients during depressive episode | Q64262134 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metformin | Q19484 |
| glimepiride | Q425027 | ||
| repaglinide | Q2195995 | ||
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 519-526 | |
| P577 | publication date | 2019-04-17 | |
| P1433 | published in | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | Q5270108 |
| P1476 | title | Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus | |
| P478 | volume | 12 |
| Q93167649 | Age-specific urinary metabolite signatures and functions in patients with major depressive disorder | cites work | P2860 |
Search more.